pubmed-article:17181919 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0009325 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:17181919 | lifeskim:mentions | umls-concept:C0442117 | lld:lifeskim |
pubmed-article:17181919 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:17181919 | pubmed:dateCreated | 2006-12-21 | lld:pubmed |
pubmed-article:17181919 | pubmed:abstractText | To determine the efficacy, tolerance and safety of intramuscular injections of porcine type I collagen-PVP in patients with RA in a long term-therapy. | lld:pubmed |
pubmed-article:17181919 | pubmed:language | eng | lld:pubmed |
pubmed-article:17181919 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17181919 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17181919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17181919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17181919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17181919 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17181919 | pubmed:issn | 0392-856X | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Alcocer-Varel... | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Furuzawa-Carb... | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Fenutria-Ausm... | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Gil-EspinosaV... | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Lozano-SotoFF | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Teliz-Meneses... | lld:pubmed |
pubmed-article:17181919 | pubmed:author | pubmed-author:Romero-TrejoC... | lld:pubmed |
pubmed-article:17181919 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17181919 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:17181919 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17181919 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17181919 | pubmed:pagination | 514-20 | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:meshHeading | pubmed-meshheading:17181919... | lld:pubmed |
pubmed-article:17181919 | pubmed:articleTitle | Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial. | lld:pubmed |
pubmed-article:17181919 | pubmed:affiliation | Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. | lld:pubmed |
pubmed-article:17181919 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17181919 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17181919 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17181919 | lld:pubmed |